Nucor Upgraded by UBS to Buy with $190 Target
UBS raises Nucor to Buy with a $190 target after a pullback, highlighting stronger than expected Q1 guidance and impr...
Index Level plays a key role across markets, signaling potential strength or weakness. Use these insights to assess opportunities and guard against risk.
27,528 articlesUBS raises Nucor to Buy with a $190 target after a pullback, highlighting stronger than expected Q1 guidance and impr...
Trespassers and tailgaters are signaling a safety challenge for elon musk’s underground transit in Las Vegas as staff...
As Q2 2026 gains momentum, XRP, Solana, and BNB post modest climbs. Investors eye price thresholds and upcoming catal...
A 58-year-old marketing director inherits a $1.2 million traditional IRA. Tax timing within the 10-year rule could sa...
A 64-year-old retired teacher with a $1.1M 403(b) and a state pension confronts higher Medicare IRMAA surcharges as M...
Palantir rode the AI wave to big gains, but recent performance has paused. This guide analyzes whether palantir stock...
Investors are shifting from FXI to a South Korea-focused ETF to capture the AI hardware boom, citing lower costs and ...
The FBI director disclosed a late Strategy stock purchase, prompting questions about STOCK Act timing and potential c...
A closer look at Janus Henderson's CLO ETFs shows a safety-first anchor in JAAA and a bolder, higher-yield challenger...
The lure of a cheap rental property can tempt beginners, but the real challenge lies in financing and hidden costs. T...
Biotech stocks can swing on clinical data and regulatory news. This guide digs into whether crispr therapeutics stock...
A quiet realignment in stablecoins is underway as Circle's USDC closes the gap with Tether's USDT, signaling a shift ...